{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T15:57:48Z","timestamp":1649174268260},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,5,30]],"date-time":"2010-05-30T00:00:00Z","timestamp":1275177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00115-010-3029-1","type":"journal-article","created":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T23:57:27Z","timestamp":1275091047000},"page":"1003-1006","source":"Crossref","is-referenced-by-count":1,"title":["Intrathekale Baclofen-Therapie bei gehf\u00e4higen Patienten mit spastischer Hemiparese nach Schlaganfall"],"prefix":"10.1007","volume":"81","author":[{"given":"S.","family":"K\u00e4stner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,30]]},"reference":[{"key":"3029_CR1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/088307389601100202","volume":"11","author":"Albright","year":"1996","unstructured":"Albright AL (1996) Baclofen in the treatment of cerebral palsy. J Child Neurol 11:77\u201383","journal-title":"J Child Neurol"},{"key":"3029_CR2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s004150050067","volume":"244","author":"Becker","year":"1997","unstructured":"Becker R, Alberti O, Bauer BL (1997) Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. J Neurol 244:160\u2013166","journal-title":"J Neurol"},{"key":"3029_CR3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","volume":"347","author":"Brashear","year":"2002","unstructured":"Brashear A, Gordon MF, Elovic E et al (2002) Botox post-stroke spasticity study group. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. N Engl J Med 347:395\u2013400","journal-title":"N Engl J Med"},{"key":"3029_CR4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3171\/jns.1993.78.2.0226","volume":"78","author":"Coffrey","year":"1993","unstructured":"Coffrey RJ, Cahill D, Steers W et al (1993) Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 78:226\u2013232","journal-title":"J Neurosurg"},{"key":"3029_CR5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.apmr.2004.08.001","volume":"86","author":"Formisano","year":"2005","unstructured":"Formisano R, Pantano P, Buzzi G et al (2005) Late motor recovery is influenced by muscle tone changes after stroke. Arch Phys Med Rehabil 86:308\u2013311","journal-title":"Arch Phys Med Rehabil"},{"key":"3029_CR6","first-page":"219","volume":"97","author":"Francisco","year":"2007","unstructured":"Francisco G (2007) Intrathecal baclofen in the management of post-stroke hypertonia: current applications and future directions. Acta Neurochir Suppl 97:219\u2013226","journal-title":"Acta Neurochir Suppl"},{"key":"3029_CR7","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0003-9993(03)00134-5","volume":"84","author":"Francisco","year":"2003","unstructured":"Francisco G, Boake C (2003) Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: A preliminary study. Arch Med Rehabil 84:1194\u20131199","journal-title":"Arch Med Rehabil"},{"key":"3029_CR8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000121223","volume":"27","author":"Gerszten","year":"1997","unstructured":"Gerszten PC, Albright AL, Barry MJ (1997) Effect on ambulation of continuous baclofen infusion. Pediatr Neurosurg 27:40\u201344","journal-title":"Pediatr Neurosurg"},{"key":"3029_CR9","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.apmr.2006.08.323","volume":"87","author":"Ivanhoe","year":"2006","unstructured":"Ivanhoe C, Francisco G, McGuire J et al (2006) Intrathecal baclofen management of poststroke spastic hypertonia: Implications for function and quality of life. Arch Phys Med Rehabil 87:1509\u20131515","journal-title":"Arch Phys Med Rehabil"},{"key":"3029_CR10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1545968308317700","volume":"23","author":"Kofler","year":"2009","unstructured":"Kofler M, Qirbach E, Schauer R et al (2009) Limitations of intrathecal baclofen for spastic hemiparesis following stroke. Neurorehabil Neural Repair 23:26\u201331","journal-title":"Neurorehabil Neural Repair"},{"key":"3029_CR11","unstructured":"Kroin JS, Penn RD (1991) Cerebrospinal fluid pharmacokinetics of lumbar intrathecal baclofen. In: Lakke JPWF, Delhaas EM, Ruttgers AWF (eds) Parenteral drug therapy in spasticity and Parkinson\u2019s disease. Parthenon Publishing, Carnforth UK, pp 73\u201383"},{"key":"3029_CR12","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/01.WNL.0000141863.52691.44","volume":"63","author":"Montane","year":"2004","unstructured":"Montane E, Vallano A, Laporte JR (2004) Oral antispastic drugs in non-progressive neurologic diseases: a systematic review. Neurology 63(8):1357\u20131363","journal-title":"Neurology"},{"key":"3029_CR13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0003-9993(96)90034-9","volume":"77","author":"Meythaler","year":"1996","unstructured":"Meythaler J, DeVivo MJ, Hadley M (1996) Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to aquired brain injury. Arch Phys Med Rehabil 77:461\u2013466","journal-title":"Arch Phys Med Rehabil"},{"key":"3029_CR14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00002060-199905000-00012","volume":"78","author":"Meythaler","year":"1999","unstructured":"Meythaler J, Guin-Renfroe S, Hadley M (1999) Continuously infused intrathecal baclofen for spastic\/dystonic hemiplegia. Am J Phys Med Rehabil 78:247\u2013254","journal-title":"Am J Phys Med Rehabil"},{"key":"3029_CR15","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/hs0901.095682","volume":"32","author":"Meythaler","year":"2001","unstructured":"Meythaler J, Guin-Renfroe S, Brunner R et al (2001) Intrathecal baclofen of spastic hypertonia from stroke. Stroke 32:2099\u20132109","journal-title":"Stroke"},{"key":"3029_CR16","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM198906083202303","volume":"320","author":"Penn","year":"1989","unstructured":"Penn RD, Savoy SM, Corcos DM et al (1989) Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320:1517\u20131522","journal-title":"N Engl J Med"},{"key":"3029_CR17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0003-9993(02)04906-7","volume":"84","author":"R\u00e9my-N\u00e9ris","year":"2003","unstructured":"R\u00e9my-N\u00e9ris O, Tiffreau V, Bouilland S, Bussel B (2003) Intrathecal baclofen in subjects with spastic hemiplegia: Assesment of antispastic effect during gait. Arch Phys Med Rehabil 84:643\u2013650","journal-title":"Arch Phys Med Rehabil"},{"key":"3029_CR18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00415-005-0060-4","volume":"253","author":"Sadiq","year":"2006","unstructured":"Sadiq S, Wang G (2006) Long-term intrathecal baclofen therapy in ambulatory patients with spasticity. J Neurol 253:563\u2013569","journal-title":"J Neurol"},{"key":"3029_CR19","first-page":"195","volume":"47","author":"Saltuari","year":"1992","unstructured":"Saltuari L, Kronenberg M, Marosi M et al (1992) Long-term intrathecal baclofen treatment for supraspinal spasticity. Acta Neurol 47:195\u2013207","journal-title":"Acta Neurol"},{"key":"3029_CR20","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/WNL.46.5.1306","volume":"46","author":"Simpson","year":"1996","unstructured":"Simpson DM, Alexander DN, O\u2019Brian CF et al (1996) Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 46:1306\u20131310","journal-title":"Neurology"},{"key":"3029_CR21","first-page":"5","volume":"42","author":"Taricco","year":"2006","unstructured":"Taricco M, Pagliacci MC, Telaro E, Adone R (2006) Pharmacological interventions for spasticity following spinal cord injury: results of a Cochrane systematic review. Eura Medicophys 42:5\u201315","journal-title":"Eura Medicophys"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-010-3029-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-010-3029-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-010-3029-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T05:08:46Z","timestamp":1558588126000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-010-3029-1"}},"subtitle":["Kurzer Bericht zweier F\u00e4lle"],"short-title":[],"issued":{"date-parts":[[2010,5,30]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["3029"],"URL":"https:\/\/doi.org\/10.1007\/s00115-010-3029-1","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,30]]}}}